Effect of Lixisenatide on Postprandial Plasma Glucose Compared to Sitagliptin in Combination With Insulin Glargine

NCT02200991 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

136

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: LIXISENATIDE AVE0010
DRUG: Sitagliptin
DRUG: Insulin glargine HOE901

Sponsor

Sanofi